Effects of apoptosis protein XIAP inhibitor on the apoptosis and sensitivity of chemotherapy in A549 cell

Chinese Journal of Lung Cancer

Volumn 11, Issue 3, 2008, Pages 368-372

  Chen, Fuhui ^a   Qu, Hongyan ^a   Sui, Guangjie ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Human XIAP protein; Lung neoplasms; RNA interference

Indexed keywords

CISPLATIN; MESSENGER RNA; SMALL INTERFERING RNA; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CELL KILLING; CELL PROLIFERATION; CONTROLLED STUDY; DNA SEQUENCE; DRUG INHIBITION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

EID: 47149083120     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2008.03.027     Document Type: Article

References (13)

1. Sun C, Cai M, Gunasekera AH, et al. NMR structure and muta-gene-sis of the inhibitor-of-apoptosis protein XIAP. Nature. 1999. 401: 818-822.
2. Holcik M, Korneluk RG. XIAP, the guardian angel. Nat Rev Mol Cell Bio, 2001, 2(7): 550-556.
3. Du C, Fang M, Li Y, et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation hy eliminating IAP inhibition. Cell, 2000, 102(1): 33-42.
4. Hofmann HS, Simm A, Hammer A, et al. Expression of inhibitor of apoptosis (IAP) proteins in non-small cell human lung cancer. J Cancer Res Clin Oncol, 2002, 128(10): 554-560.
5. Ramp II, Krieg T, Caliskan E, et al. XIAP expression is an independent prognostic marker in clear-cell renal carcinomas. Hum Pathol, 2004, 35(8): 1022-1028.
6. Tamm I, Kornblau SM, Segall H, et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res, 2000, 6(5): 1796-1803.
7. Bilim V, Kasahara T, Hara N, et al. Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug resistant TCC in vitro. Int J Cancer, 2003, 103(1): 29-37.
8. Carter BZ, Milella M, Tsao T, et al. Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia. Leukemia, 2003, 17(11): 2081-2089.
9. Li J, Feng Q, Kim JM, et al. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology, 2001, 142(1): 370-380.
10. Yang L, Cao Z, Yan H, el al. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res, 2003, 63(20): 6815-6824.
11. Hu Y, Cherton-Horvat G, Dragowska V, et al. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res. 2003, 9(7): 2826-2836.
12. Lima RT, Martin LM, Guimarace JE, et al. Specific downregulalion of bcl-2 and XIAP by RNAi enhances the effects of chemotherapeuticagents in MCF-7 human breast cancer cells. Cancer Gene Ther, 2004,11(4): 309-316.
13. McManus DC, Lefebvre CA, Cherton HG, et al. Loss of XIAP prrotein exprsssion by RNAi and antisense approaches sensitizes cancer cell to functionally diverse chemotherapeutics. Oncogene, 2004, 23(49): 8105-8117.